GlassScriptPhysician profile
Maryrita K Mallet
NPI 1366478182
$5,218.34
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,053 · 2020: $1,074 · 2021: $1,351 · 2022: $751 · 2023: $929 · 2024: $61.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $879 · Education: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $878.81 |
| Education | $111.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $2,859.21 | 2019-2024 | Austedo Xr, Austedo |
| Alkermes, INC. | $691.26 | 2019-2024 | Aristada, Lybalvi |
| Lundbeck LLC | $388.10 | 2020-2023 | Abilify Maintena, Rexulti |
| Janssen Pharmaceuticals, INC | $353.96 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $256.39 | 2019-2023 | Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $187.92 | 2020-2023 | |
| Neurocrine Biosciences, INC. | $139.88 | 2020-2022 | |
| Avanir Pharmaceuticals, INC. | $120.33 | 2019-2022 | |
| Ironshore Pharmaceuticals INC. | $51.34 | 2019-2020 | |
| Indivior INC. | $46.09 | 2019 | |
| Adlon Therapeutics L.P. | $37.75 | 2020-2021 | |
| Abbvie INC. | $24.93 | 2021 | |
| Axsome Therapeutics, INC. | $20.59 | 2023 | Auvelity |
| Noven Therapeutics, LLC | $14.40 | 2020 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $13.86 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $12.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maryrita Mallet listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.